D-0261-2024 Class I Ongoing

Recalled by PFIZER — New York, NY

FDA drug recall D-0261-2024 was initiated by PFIZER on Dec 21, 2023 and is designated Class I. Reason for recall: Presence of particulate matter: glass The recall status is ongoing. Affected quantity: 3,546 vials.

Recall details

Product Type
Drugs
Report Date
Jan 31, 2024
Initiation Date
Dec 21, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,546 vials

Product description

Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18

Reason for recall

Presence of particulate matter: glass

Distribution pattern

Nationwide in the USA, Netherlands and Libya

Code information

Lot #: BL12206A, Exp date 06/30/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0261-2024
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for PFIZER? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0261-2024. Report a data issue: hello@regdatalab.com.